TriApex - Crunchbase Company Profile & Funding

Q: Where is TriApex's headquarters?

TriApex is located in Nanjing, Jiangsu, China.

Q: Who invested in TriApex?

TriApex is funded by Legend Capital.

Q: When was the last funding round for TriApex?

TriApex closed its last funding round on obfuscated from a Series C round.

Overview

TriApex

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About TriApex

CB Rank

490501

TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises.

Founded

obfuscation

Private

Series C

Nanjing, Jiangsu, China

501-1000

www.tri-apex.com/

Biopharma

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Details

Sub-Organization of

Tripod Preclinical Research Laboratories

Legal Name

TriApex Laboratories Co., Ltd

Also Known As

江苏鼎泰药物研究

Operating Status

Active

Company Type

For Profit

About the Company

TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

Phone Number

(025) 5819-6588

Contact Email

BD@tri-apex.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Disease Models and Pharmacodynamics

Provides in vivo and in vitro disease models and pharmacodynamic studies focused on ophthalmic, CNS, metabolic, cardiovascular, and other diseases to support drug research and development.

Regulatory Strategies and Safety Assessment

Offers regulatory strategy consulting and conducts safety assessments including toxicology, pharmacokinetics, and safety pharmacology studies to support drug development compliance.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C
obfuscated obfuscation	Series C - TriApex	1	obfuscated obfuscation	Legend Capital	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Legend Capital	Yes	Series C - TriApex	Hank Zhou
Legend Capital	Yes	Series C - TriApex	Hank Zhou
Legend Capital	Yes	Series C - TriApex	Hank Zhou
Legend Capital	Yes	Series C - TriApex	Hank Zhou
Legend Capital	Yes	Series C - TriApex	Hank Zhou

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation
obfuscated obfuscation	Xellar Biosystems	Yes	Seed Round - Xellar Biosystems	obfuscated obfuscation